HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs

J Virol. 2018 Mar 14;92(7):e01633-17. doi: 10.1128/JVI.01633-17. Print 2018 Apr 1.

Abstract

HIV-1 downregulates human leukocyte antigen A (HLA-A) and HLA-B from the surface of infected cells primarily to evade CD8 T cell recognition. HLA-C was thought to remain on the cell surface and bind inhibitory killer immunoglobulin-like receptors, preventing natural killer (NK) cell-mediated suppression. However, a recent study found HIV-1 primary viruses have the capacity to downregulate HLA-C. The goal of this study was to assess the heterogeneity of HLA-A, HLA-B, and HLA-C downregulation among full-length primary viruses from six chronically infected and six newly infected individuals from transmission pairs and to determine whether transmitted/founder variants exhibit common HLA class I downregulation characteristics. We measured HLA-A, HLA-B, HLA-C, and total HLA class I downregulation by flow cytometry of primary CD4 T cells infected with 40 infectious molecular clones. Primary viruses mediated a range of HLA class I downregulation capacities (1.3- to 6.1-fold) which could differ significantly between transmission pairs. Downregulation of HLA-C surface expression on infected cells correlated with susceptibility to in vitro NK cell suppression of virus release. Despite this, transmitted/founder variants did not share a downregulation signature and instead were more similar to the quasispecies of matched donor partners. These data indicate that a range of viral abilities to downregulate HLA-A, HLA-B, and HLA-C exist within and between individuals that can have functional consequences on immune recognition.IMPORTANCE Subtype C HIV-1 is the predominant subtype involved in heterosexual transmission in sub-Saharan Africa. Authentic subtype C viruses that contain natural sequence variations throughout the genome often are not used in experimental systems due to technical constraints and sample availability. In this study, authentic full-length subtype C viruses, including transmitted/founder viruses, were examined for the ability to disrupt surface expression of HLA class I molecules, which are central to both adaptive and innate immune responses to viral infections. We found that the HLA class I downregulation capacity of primary viruses varied, and HLA-C downregulation capacity impacted viral suppression by natural killer cells. Transmitted viruses were not distinct in the capacity for HLA class I downregulation or natural killer cell evasion. These results enrich our understanding of the phenotypic variation existing among natural HIV-1 viruses and how that might impact the ability of the immune system to recognize infected cells in acute and chronic infection.

Keywords: HIV-1; HLA; NK cells; Nef; Vpu; human immunodeficiency virus; human leukocyte antigen class I; natural killer cells; quasispecies; transmitted/founder virus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections / immunology*
  • HIV Infections / transmission
  • HIV Infections / virology
  • HIV Seropositivity
  • HIV-1 / classification
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HLA-A Antigens / chemistry*
  • HLA-A Antigens / immunology
  • HLA-B Antigens / chemistry*
  • HLA-B Antigens / immunology
  • HLA-C Antigens / chemistry*
  • HLA-C Antigens / immunology
  • Host-Pathogen Interactions / genetics
  • Host-Pathogen Interactions / immunology*
  • Human Immunodeficiency Virus Proteins / metabolism
  • Humans
  • Immune Evasion / immunology*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Viral Regulatory and Accessory Proteins / metabolism
  • nef Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-C Antigens
  • Human Immunodeficiency Virus Proteins
  • Viral Regulatory and Accessory Proteins
  • nef Gene Products, Human Immunodeficiency Virus
  • vpu protein, Human immunodeficiency virus 1